Keyphrases
Confidence Interval
100%
Major Bleeding
100%
Low Risk
100%
Venous Thromboembolism
100%
Rivaroxaban
100%
Bleeding Risk Score
100%
Deep Vein Thrombosis
33%
Bleeding
33%
Pulmonary Embolism
22%
Bleeding Risk
22%
Vitamin K Antagonists
22%
Myocardial Infarction
11%
Blood Transfusion
11%
Clinical Significance
11%
Comorbid Conditions
11%
Patient Selection
11%
Anemia
11%
Treatment Duration
11%
Anticoagulation
11%
Type 1 Diabetes Mellitus (T1DM)
11%
Antagonist Treatment
11%
Routine Clinical Practice
11%
Recurrent Venous Thromboembolism
11%
Prior Stroke
11%
Renal Insufficiency
11%
Bleeding History
11%
Major Bleed
11%
Drop in Hemoglobin
11%
Scoring System
11%
Bleed Rate
11%
Critical Bleeding
11%
Pharmacology, Toxicology and Pharmaceutical Science
Rivaroxaban
100%
Venous Thromboembolism
100%
Bleeding
100%
Deep Vein Thrombosis
37%
Lung Embolism
25%
Antivitamin K
25%
Ciclonicate
25%
Malignant Neoplasm
12%
Anemia
12%
Diabetes Mellitus
12%
Heart Infarction
12%
Kidney Failure
12%
Cerebrovascular Accident
12%
INIS
patients
100%
risks
100%
comparative evaluations
100%
veins
27%
thrombosis
27%
vitamin k
18%
cancer
9%
blood
9%
myocardial infarction
9%
diabetes mellitus
9%
transfusions
9%
death
9%
kidneys
9%
accuracy
9%
hemoglobin
9%
anemias
9%
assignments
9%
Neuroscience
Rivaroxaban
100%
Deep Vein Thrombosis
60%
Vitamin K Antagonist
40%
Pulmonary Embolism
40%
Diabetes Mellitus
20%
Myocardial Infarction
20%
Cerebrovascular Accident
20%